Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. (TVGN): 2 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
1.2 months
D/E -1.50 · 0% dilution
Lead: Phase 1
2 candidates
N/A
0 buys · 3 sells (180d)
A transparent, data-derived signal for Tevogen Bio Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$40.9M
Cash
$692K
Quarterly Burn
$2.7M
Runway
1.2 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| tvgn 489 | Phase 1 |
| unspecified | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
28
Total value held
$722K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 66,496 | $301K |
| blackrock, inc. | 24,395 | $110K |
| morgan stanley | 17,334 | $78K |
| geode capital management, llc | 15,734 | $71K |
| deutsche bank ag\ | 15,324 | $69K |
| fmr llc | 10,157 | $46K |
| vanguard portfolio management llc | 4,525 | $20K |
| vanguard fiduciary trust co | 1,368 | $6K |
| rhumbline advisers | 1,003 | $5K |
| tower research capital llc (trc) | 941 | $4K |
Showing top 10 of 28 institutional holders of Tevogen Bio Holdings Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Tevogen Bio Holdings Inc.'s pipeline?
Tevogen Bio Holdings Inc. (TVGN) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Tevogen Bio Holdings Inc.'s lead drug candidate?
Tevogen Bio Holdings Inc.'s most advanced tracked candidate is tvgn 489 (Phase 1) for COVID-19 and Long COVID.
What is Tevogen Bio Holdings Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Tevogen Bio Holdings Inc. has approximately 1.2 months of cash runway.
What is Tevogen Bio Holdings Inc.'s market capitalization?
Tevogen Bio Holdings Inc.'s market capitalization is approximately $40.9M.
Who is the CEO of Tevogen Bio Holdings Inc.?
Dr. Ryan H. Saadi M.D., M.P.H. is the chief executive officer of Tevogen Bio Holdings Inc. (TVGN).
Get the full picture on Tevogen Bio Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.